Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invamed is a leading medical technology company focused on the development and manufacture of innovative cardiovascular and vascular devices. Headquartered in Turkey, the company operates one of the largest medical device R&D and production facilities in the region, producing a wide array of products including stents, catheters, and venous closure systems. Their flagship products, such as the VenaBlock system, are used globally for the minimally invasive treatment of chronic venous insufficiency and other vascular conditions. Invamed is committed to advancing interventional medicine through continuous innovation and high-standard manufacturing processes. The company distributes its medical solutions to over 70 countries, serving healthcare providers in interventional radiology, cardiology, and cardiovascular surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invamed.